Insider: Mancini Marianna Chief Operating Officer - Viking Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 434,890 | 0 | 434,890 |
| Value | $15,134,172.00 | $0.00 | $15,134,172.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/05/2026 | DDS | 31,961 | Direct | COM | $32.29 | $1,032,110.18 | 434,890 |
| 01/05/2026 | DDS | 13,600 | Direct | COM | $33.37 | $453,875.52 | 421,290 |
| 01/05/2026 | DDS | 10,500 | Direct | COM | $34.22 | $359,302.65 | 410,790 |
| 01/05/2026 | DDS | 1,600 | Direct | COM | $35.07 | $56,116.96 | 409,190 |
| 10/28/2025 | DDS | 6,185 | Direct | COM | $35.00 | $216,491.70 | 382,467 |
| 07/03/2025 | DDS | 4,266 | Direct | COM | $27.77 | $118,472.79 | 377,535 |
| 01/06/2025 | DDS | 49,115 | Direct | COM | $42.69 | $2,096,684.97 | 379,234 |
| 01/06/2025 | DDS | 5,100 | Direct | COM | $43.32 | $220,914.15 | 374,134 |
| 07/30/2024 | DDS | 14,704 | Direct | COM | $56.98 | $837,833.92 | 365,471 |
| 07/30/2024 | DDS | 3,322 | Direct | COM | $57.82 | $192,078.04 | 362,149 |
| 05/01/2024 | DDS | 23,746 | Direct | COM | $76.40 | $1,814,301.26 | 606,187 |
| 05/01/2024 | DDS | 6,248 | Direct | COM | $80.08 | $500,310.47 | 348,508 |
| 05/01/2024 | DDS | 26,142 | Direct | COM | $77.49 | $2,025,829.85 | 580,045 |
| 05/01/2024 | DDS | 119,946 | Direct | COM | $79.29 | $9,511,058.10 | 354,756 |
| 05/01/2024 | DDS | 105,343 | Direct | COM | $78.65 | $8,284,974.13 | 474,702 |
| 04/17/2023 | DDS | 12,500 | Direct | COM | $20.00 | $250,000.00 | 287,763 |
| 03/29/2023 | DDS | 41,242 | Direct | COM | $16.00 | $659,872.00 | 261,895 |
| 03/28/2023 | DDS | 196,563 | Direct | COM | $15.00 | $2,948,445.00 | 288,137 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research